Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Biological Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Biological Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Biological Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Shire
Biogen
Pfizer
Bristol-Myers Squibb
Baxter
Merck
Johnson & Johnson
Novartis
F Hoffmann-La Roche
Amgen
GlaxoSmithKline
Eli Lilly
Abbott Laboratories
By Type:
Therapeutic Protein
Monoclonal Antibody
Vaccine
By End-User:
Hospitals
Ambulatory Surgical Centers
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Biological Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 USA Biological Drugs Market Size and Growth Rate of Therapeutic Protein from 2016 to 2027
-
1.3.2 USA Biological Drugs Market Size and Growth Rate of Monoclonal Antibody from 2016 to 2027
-
1.3.3 USA Biological Drugs Market Size and Growth Rate of Vaccine from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Biological Drugs Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 USA Biological Drugs Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027
-
1.4.3 USA Biological Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Biological Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Biological Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Biological Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Biological Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Biological Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Biological Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Therapeutic Protein
-
3.4.2 Market Size and Growth Rate of Monoclonal Antibody
-
3.4.3 Market Size and Growth Rate of Vaccine
4 Segmentation of Biological Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Biological Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Biological Drugs in Hospitals
-
4.4.2 Market Size and Growth Rate of Biological Drugs in Ambulatory Surgical Centers
-
4.4.3 Market Size and Growth Rate of Biological Drugs in Others
5 Market Analysis by Regions
-
5.1 USA Biological Drugs Production Analysis by Regions
-
5.2 USA Biological Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Biological Drugs Landscape Analysis
-
6.1 West USA Biological Drugs Landscape Analysis by Major Types
-
6.2 West USA Biological Drugs Landscape Analysis by Major End-Users
7 South USA Biological Drugs Landscape Analysis
-
7.1 South USA Biological Drugs Landscape Analysis by Major Types
-
7.2 South USA Biological Drugs Landscape Analysis by Major End-Users
8 Middle West USA Biological Drugs Landscape Analysis
-
8.1 Middle West USA Biological Drugs Landscape Analysis by Major Types
-
8.2 Middle West USA Biological Drugs Landscape Analysis by Major End-Users
9 Northeast USA Biological Drugs Landscape Analysis
-
9.1 Northeast USA Biological Drugs Landscape Analysis by Major Types
-
9.2 Northeast USA Biological Drugs Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Shire
-
10.1.1 Shire Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Biogen
-
10.2.1 Biogen Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Pfizer
-
10.3.1 Pfizer Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Bristol-Myers Squibb
-
10.4.1 Bristol-Myers Squibb Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Baxter
-
10.5.1 Baxter Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Merck
-
10.6.1 Merck Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Johnson & Johnson
-
10.7.1 Johnson & Johnson Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Novartis
-
10.8.1 Novartis Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 F Hoffmann-La Roche
-
10.9.1 F Hoffmann-La Roche Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Amgen
-
10.10.1 Amgen Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 GlaxoSmithKline
-
10.11.1 GlaxoSmithKline Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Eli Lilly
-
10.12.1 Eli Lilly Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Abbott Laboratories
-
10.13.1 Abbott Laboratories Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Biological Drugs Market Size and Growth Rate of Therapeutic Protein from 2016 to 2027
-
Figure USA Biological Drugs Market Size and Growth Rate of Monoclonal Antibody from 2016 to 2027
-
Figure USA Biological Drugs Market Size and Growth Rate of Vaccine from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Biological Drugs Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure USA Biological Drugs Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027
-
Figure USA Biological Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Biological Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Biological Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Biological Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Biological Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Biological Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Biological Drugs
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Biological Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Biological Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Therapeutic Protein
-
Figure Market Size and Growth Rate of Monoclonal Antibody
-
Figure Market Size and Growth Rate of Vaccine
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Biological Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Biological Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Ambulatory Surgical Centers
-
Figure Market Size and Growth Rate of Others
-
Table USA Biological Drugs Production by Regions
-
Table USA Biological Drugs Production Share by Regions
-
Figure USA Biological Drugs Production Share by Regions in 2016
-
Figure USA Biological Drugs Production Share by Regions in 2021
-
Figure USA Biological Drugs Production Share by Regions in 2027
-
Table USA Biological Drugs Consumption by Regions
-
Table USA Biological Drugs Consumption Share by Regions
-
Figure USA Biological Drugs Consumption Share by Regions in 2016
-
Figure USA Biological Drugs Consumption Share by Regions in 2021
-
Figure USA Biological Drugs Consumption Share by Regions in 2027
-
Table West USA Biological Drugs Consumption by Types from 2016 to 2027
-
Table West USA Biological Drugs Consumption Share by Types from 2016 to 2027
-
Figure West USA Biological Drugs Consumption Share by Types in 2016
-
Figure West USA Biological Drugs Consumption Share by Types in 2021
-
Figure West USA Biological Drugs Consumption Share by Types in 2027
-
Table West USA Biological Drugs Consumption by End-Users from 2016 to 2027
-
Table West USA Biological Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Biological Drugs Consumption Share by End-Users in 2016
-
Figure West USA Biological Drugs Consumption Share by End-Users in 2021
-
Figure West USA Biological Drugs Consumption Share by End-Users in 2027
-
Table South USA Biological Drugs Consumption by Types from 2016 to 2027
-
Table South USA Biological Drugs Consumption Share by Types from 2016 to 2027
-
Figure South USA Biological Drugs Consumption Share by Types in 2016
-
Figure South USA Biological Drugs Consumption Share by Types in 2021
-
Figure South USA Biological Drugs Consumption Share by Types in 2027
-
Table South USA Biological Drugs Consumption by End-Users from 2016 to 2027
-
Table South USA Biological Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Biological Drugs Consumption Share by End-Users in 2016
-
Figure South USA Biological Drugs Consumption Share by End-Users in 2021
-
Figure South USA Biological Drugs Consumption Share by End-Users in 2027
-
Table Middle West USA Biological Drugs Consumption by Types from 2016 to 2027
-
Table Middle West USA Biological Drugs Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Biological Drugs Consumption Share by Types in 2016
-
Figure Middle West USA Biological Drugs Consumption Share by Types in 2021
-
Figure Middle West USA Biological Drugs Consumption Share by Types in 2027
-
Table Middle West USA Biological Drugs Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Biological Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Biological Drugs Consumption Share by End-Users in 2016
-
Figure Middle West USA Biological Drugs Consumption Share by End-Users in 2021
-
Figure Middle West USA Biological Drugs Consumption Share by End-Users in 2027
-
Table Northeast USA Biological Drugs Consumption by Types from 2016 to 2027
-
Table Northeast USA Biological Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Biological Drugs Consumption Share by Types in 2016
-
Figure Northeast USA Biological Drugs Consumption Share by Types in 2021
-
Figure Northeast USA Biological Drugs Consumption Share by Types in 2027
-
Table Northeast USA Biological Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Biological Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Biological Drugs Consumption Share by End-Users in 2016
-
Figure Northeast USA Biological Drugs Consumption Share by End-Users in 2021
-
Figure Northeast USA Biological Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Shire
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire
-
Figure Sales and Growth Rate Analysis of Shire
-
Figure Revenue and Market Share Analysis of Shire
-
Table Product and Service Introduction of Shire
-
Table Company Profile and Development Status of Biogen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen
-
Figure Sales and Growth Rate Analysis of Biogen
-
Figure Revenue and Market Share Analysis of Biogen
-
Table Product and Service Introduction of Biogen
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of Baxter
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter
-
Figure Sales and Growth Rate Analysis of Baxter
-
Figure Revenue and Market Share Analysis of Baxter
-
Table Product and Service Introduction of Baxter
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of F Hoffmann-La Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche
-
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche
-
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche
-
Table Product and Service Introduction of F Hoffmann-La Roche
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of Abbott Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories
-
Figure Sales and Growth Rate Analysis of Abbott Laboratories
-
Figure Revenue and Market Share Analysis of Abbott Laboratories
-
Table Product and Service Introduction of Abbott Laboratories
-
